GreenLight Biosciences Holdings
GRNA · NASDAQ
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$28,469 | -$38,764 | -$38,158 | -$51,926 |
| Dep. & Amort. | $2,334 | $2,199 | $1,757 | $2,024 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2,308 | $2,318 | $2,700 | $1,634 |
| Change in WC | -$8,146 | $4,877 | -$7,003 | $26,761 |
| Other Non-Cash | $913 | $4,781 | $727 | -$1,190 |
| Operating Cash Flow | -$31,060 | -$24,589 | -$39,977 | -$22,697 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,608 | -$3,603 | -$10,074 | -$12,583 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$1,608 | -$3,603 | -$10,074 | -$12,583 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | -$310 | $106,339 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2,989 | -$2,064 | $104,272 | -$3,811 |
| Financing Cash Flow | -$2,989 | -$2,064 | $104,272 | -$3,811 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$35,657 | -$30,256 | $54,221 | -$39,091 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $69,418 | $99,674 | $45,453 | $84,544 |
| End Cash | $33,761 | $69,418 | $99,674 | $45,453 |
| Free Cash Flow | -$32,668 | -$28,192 | -$50,051 | -$35,280 |